Literature DB >> 4105938

Complement utilization by guinea pig 1 and 2-immunoglobulins through the C3 activator system.

A L Sandberg, O Götze, H J Müller-Eberhard, A G Osler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4105938

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  11 in total

1.  Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin.

Authors:  T T Provost; T B Tomasi
Journal:  Clin Exp Immunol       Date:  1974-10       Impact factor: 4.330

2.  Production of histamine-like and prostaglandin-like substances from serum incubated with rat, dog, mouse or human tumours.

Authors:  M C Apps; D B Cater
Journal:  Br J Exp Pathol       Date:  1973-04

3.  Further studies on the biological properties of guinea-pig IgG1 antibodies. III. Haemolytic efficiency in vitro.

Authors:  P Vuagnat
Journal:  Immunology       Date:  1977-01       Impact factor: 7.397

Review 4.  The role of antibody in the activation of the alternative complement pathway.

Authors:  W D Ratnoff; D T Fearon; K F Austen
Journal:  Springer Semin Immunopathol       Date:  1983

5.  Insoluble polyanions as activators of both pathways of complement.

Authors:  R Burger; D Bitter-Suermann; M Loos; U Hadding
Journal:  Immunology       Date:  1977-12       Impact factor: 7.397

6.  The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes.

Authors:  J R Wands; E Mann; E Alpert; K J Isselbacher
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

7.  Inhibition of zymosan-induced alternative complement pathway activation by concanavalin A.

Authors:  M C Smith; J Pensky; G B Naff
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.

Authors:  E J Ruley; J Forristal; N C Davis; C Andres; C D West
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

9.  Pathopysiological aspects of immune complex diseases. Part II. Phagocytosis, exocytosis, and pathogenic depositions.

Authors:  H H Sedlacek
Journal:  Klin Wochenschr       Date:  1980-06-16

10.  Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritis.

Authors:  R H McLean; A F Michael
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.